Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development CODX Q1 2026 Earnings WiderthanExpected Loss Amidst No Revenue ASTH Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Tredegar Corporation Q4 2025 Earnings Profitability Rises Despite Revenue Uncertainty C3ai Q1 2026 Earnings WiderThanExpected Loss and Tepid Market Reception HELE Q1 2026 Earnings EPS Beats Estimates Stock Gains